Additionally, Berberine has shown promise in managing metabolic disorders such as diabetes and obesity, which are closely linked with accelerated aging. By improving insulin sensitivity and reducing glucose production in the liver, Berberine helps manage blood sugar levels and lipid metabolism, potentially reducing the risk of metabolic diseases.
A unique quality of Berberine is its suspected ability to inhibit ROCK2, PIK3CD, KCNMA1, CSF1R, and KIT Kinase enzymes, and in a 2023 study, was suggested that Berberine is similar to nature's own version of Imatinib or Dasatinib, the powerful anti-cancer drug used in the groundbreaking D + Q senolytic treatment.
Berberine, a bioactive compound extracted from several plants such as Coptis chinensis, has garnered attention for its anti-aging potential.One of the key mechanisms of Berberine is its activation of AMP-activated protein kinase (AMPK), often referred to as a “metabolic master switch”. Activation of AMPK improves metabolic efficiency and energy homeostasis, which are crucial for slowing down the aging process. Enhanced AMPK activity is associated with reducing mitochondrial dysfunction and promotes the removal of damaged cells through autophagy, thus preventing the accumulation of cellular debris and supporting cellular rejuvenation.
Additionally, Berberine has shown promise in managing metabolic disorders such as diabetes and obesity, which are closely linked with accelerated aging. By improving insulin sensitivity and reducing glucose production in the liver, Berberine helps manage blood sugar levels and lipid metabolism, potentially reducing the risk of metabolic diseases.
A unique quality of Berberine is its suspected ability to inhibit ROCK2, PIK3CD, KCNMA1, CSF1R, and KIT Kinase enzymes, and in a 2023 study, was suggested that Berberine is similar to nature’s own version of Imatinib or Dasatinib, the powerful anti-cancer drug used in the groundbreaking D + Q senolytic treatment.
Reviews
There are no reviews yet.